# A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD

> **NCT07076290** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Rise Therapeutics LLC** · enrollment: 27 (estimated)

## Conditions studied

- COPD (Chronic Obstructive Pulmonary Disease)
- COPD Exacerbation
- COPD Exacerbation Acute

## Interventions

- **DRUG:** R-3750

## Key facts

- **NCT ID:** NCT07076290
- **Lead sponsor:** Rise Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07076290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07076290, "A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07076290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*